Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lifecare ASAFRA:LFC0 +0.36%8 EV-to-EBITDA is -1.33 as of Aug. 17, 2026. GuruFocus rates FRA:LFC0 with a GF Score™ of 8/100 and a GF Value™ of €0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 513 Medical Devices & Instruments companies, Lifecare ASA ranks worse than 194931.58% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lifecare ASA's enterprise value is €13.27 Mil.
Lifecare ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €-9.98 Mil. Therefore, Lifecare ASA's EV-to-EBITDA for today is -1.33.
The historical rank and industry rank for Lifecare ASA's EV-to-EBITDA or its related term are showing as below:
FRA:LFC0'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -31.8 Med: -1.8 Max: -0.53
Current: -1.26
During the past 11 years, the highest EV-to-EBITDA of Lifecare ASA was -0.53. The lowest was -31.80. And the median was -1.80.
FRA:LFC0's EV-to-EBITDA is ranked worse than 100% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.95
vs FRA:LFC0: -1.26
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Lifecare ASA's PE Ratio (TTM) for today is calculated as:
Lifecare ASA's share price for today is €0.0276.
Lifecare ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Lifecare ASA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LFC0 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Lifecare ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecare ASA EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Lifecare ASA's EV-to-EBITDA falls into.
Lifecare ASA's current Enterprise Value is €13.27 Mil.
Lifecare ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-9.98 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecare ASA (FRA:LFC0) has a EV-to-EBITDA of -1.33 as of Aug. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Lifecare ASA. According to the industry distribution chart, Lifecare ASA ranks #999999 out of 513 companies in the Medical Devices & Instruments industry.
Is Lifecare ASA's EV-to-EBITDA too high?
Lifecare ASA's current EV-to-EBITDA is -1.33. Based on the distribution chart, Lifecare ASA ranks #999999 out of 513 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lifecare ASA has a GF Score™ of 8/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #999999 out of 513 companies for EV-to-EBITDA. This places Lifecare ASA in the lower half of its industry. The industry median EV-to-EBITDA is 14.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.95, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Lifecare ASA. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecare ASA's current EV-to-EBITDA is -1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (FRA:LFC0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.24, compared to a current price of €0.03 — trading 88.5% below its estimated fair value. The current EV-to-EBITDA is -1.33. Lifecare ASA's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Lifecare ASA (FRA:LFC0), the current EV-to-EBITDA is -1.33 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecare ASA (FRA:LFC0) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecare ASA stock appears to be undervalued.
The current stock price of €0.03 is trading 88.5% below its estimated GF Value™ of €0.24.
GuruFocus considers Lifecare ASA to be Possible Value Trap.
Key valuation signals for FRA:LFC0:
EV-to-EBITDA: -1.33
GF Value™: €0.24 vs. price of €0.03 (88.5% below fair value)
No single metric tells the full story. See the FRA:LFC0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
8GF Score
Get the complete analysis for FRA:LFC0
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LFC0 has been successfully added to your 
